HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with Bevacizumab, Gemcitabine and Cisplatin.

AuthorsR Dersch, O Stich, K Goller, S Meckel, F Dechent, S Doostkam, C Weiller, J Bardutzky
JournalJournal of neurology (J Neurol) Vol. 260 Issue 5 Pg. 1406-7 (May 2013) ISSN: 1432-1459 [Electronic] Germany
PMID23430165 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Deoxycytidine
  • Bevacizumab
  • Cisplatin
  • Gemcitabine
Topics
  • Adult
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Bevacizumab
  • Brain (pathology)
  • Cisplatin (therapeutic use)
  • Deoxycytidine (analogs & derivatives, therapeutic use)
  • Female
  • Humans
  • Immunologic Factors (therapeutic use)
  • Magnetic Resonance Imaging
  • Posterior Leukoencephalopathy Syndrome (drug therapy)
  • Gemcitabine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: